Safety of fluticasone propionate HFA in treating children 4-11 years of age with asthma*1

Efficacy and safety of fluticasone propionate hydrofluoroalkane inhalation aerosol in pre–school-age children with asthma: A randomized, double-blind, placebo-controlled study

“…A similar lack of effect of FP on UC excretion was observed in other studies in children. 4,15,[21][22][23][24][25][26][27][28] Specifically, there was no correlation between FP systemic exposure and change in UC from baseline. The FP HFA formulation had safety and tolerability profiles similar to those of placebo in this study.…”